UBS Group
KRMD icon

UBS Group’s KORU Medical Systems KRMD Stock Holding History

UBS Group’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.5K Sell
14,929
-2,088
-12% -$10.3K ﹤0.01% 7232
2025
Q4 		$98.9K Sell
17,017
-1,817
-10% -$8.7K ﹤0.01% 6918
2025
Q3 		$72.1K Buy
18,834
+1,565
+9% +$5.99K ﹤0.01% 7318
2025
Q2 		$61.8K Buy
17,269
+13,080
+312% +$37.2K ﹤0.01% 7595
2025
Q1 		$10.6K Buy
4,189
+1,636
+64% +$6.08K ﹤0.01% 8610
2024
Q4 		$9.83K Buy
2,553
+1,665
+188% +$5.41K ﹤0.01% 8337
2024
Q3 		$2.42K Sell
888
-17,555
-95% -$43.3K ﹤0.01% 8431
2024
Q2 		$48.9K Sell
18,443
-17,440
-49% -$39.9K ﹤0.01% 6706
2024
Q1 		$84.7K Buy
35,883
+803
+2% +$1.72K ﹤0.01% 6295
2023
Q4 		$86.1K Buy
35,080
+17,380
+98% +$41.4K ﹤0.01% 6259
2023
Q3 		$47.8K Sell
17,700
-2,812
-14% -$7.7K ﹤0.01% 6317
2023
Q2 		$70.8K Buy
20,512
+19,670
+2,336% +$77.2K ﹤0.01% 6263
2023
Q1 		$3.55K Buy
+842
New +$3.31K ﹤0.01% 8303
2022
Q2 		– Sell
-3,473
Closed -$10K – 10644
2022
Q1 		$10K Sell
3,473
-617
-15% -$1.85K ﹤0.01% 8419
2021
Q4 		$12K Buy
4,090
+668
+20% +$2.05K ﹤0.01% 8560
2021
Q3 		$10K Sell
3,422
-15,684
-82% -$51.9K ﹤0.01% 8002
2021
Q2 		$88K Buy
19,106
+13,070
+217% +$51.3K ﹤0.01% 5977
2021
Q1 		$21K Sell
6,036
-5,980
-50% -$25.9K ﹤0.01% 7335
2020
Q4 		$72K Sell
12,016
-786
-6% -$4.4K ﹤0.01% 5910
2020
Q3 		$93K Sell
12,802
-31,790
-71% -$282K ﹤0.01% 5231
2020
Q2 		$400K Buy
44,592
+29,592
+197% +$299K ﹤0.01% 4325
2020
Q1 		$113K Buy
15,000
+14,898
+14,606% +$100K ﹤0.01% 5185
2019
Q4 		$1K Buy
+102
New +$497 ﹤0.01% 7954

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $109M AUM
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

UBS Group's KRMD Position: Q1 2026 in Review

UBS Group reduced its KORU Medical Systems (KRMD) stake by 12% in Q1 2026, selling an estimated $10.3K and leaving 14,929 shares worth $64.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7232.

UBS Group first reported a position in KRMD in Q4 2019 and has held it in 23 quarters since. The position peaked at $400K in Q2 2020. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

  • UBS Group held 14,929 shares of KORU Medical Systems worth $64.5K as of Q1 2026.
  • UBS Group sold 2,088 KORU Medical Systems shares in Q1 2026, an estimated $10.3K.
  • KORU Medical Systems made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7232 holding.
  • UBS Group first reported a position in KORU Medical Systems in Q4 2019 and has held it in 23 quarters since.
  • UBS Group's KORU Medical Systems position peaked at $400K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.